{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:34:37Z","timestamp":1793230477537,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.biopha.2025.118097","type":"journal-article","created":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T23:39:24Z","timestamp":1745710764000},"page":"118097","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Naphthalimide derivative attenuates tumor growth of wild-type p53\u2013expressing U87 glioma cells in vitro and in vivo through a biphasic dose-dependent mechanism: A switch from cell cycle to apoptosis"],"prefix":"10.1016","volume":"187","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1519-1797","authenticated-orcid":false,"given":"Kuan-Hung","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8838-3215","authenticated-orcid":false,"given":"Jiun-Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4666-6364","authenticated-orcid":false,"given":"Ray-Jade","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Ju","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3100-0121","authenticated-orcid":false,"given":"Hsueh-Hsiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsien-Yu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Jung","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118097_bib1","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 world health organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.biopha.2025.118097_bib2","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.biopha.2025.118097_bib3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12943-022-01513-z","article-title":"Glioma targeted therapy: insight into future of molecular approaches","volume":"21","author":"Yang","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2025.118097_bib4","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.chembiol.2018.11.009","article-title":"Discovery of Small-Molecule Inhibitors of the HSP90-Calcineurin-NFAT Pathway against Glioblastoma","volume":"26","author":"Liu","year":"2019","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.biopha.2025.118097_bib5","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.yexmp.2011.09.005","article-title":"Calcium entry via ORAI1 regulates glioblastoma cell proliferation and apoptosis","volume":"91","author":"Liu","year":"2011","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.biopha.2025.118097_bib6","first-page":"1001","article-title":"The MDM2-p53 interaction","volume":"1","author":"Moll","year":"2003","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.biopha.2025.118097_bib7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41573-022-00571-8","article-title":"Drugging p53 in cancer: one protein, many targets","volume":"22","author":"Hassin","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2025.118097_bib8","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nrc2657","article-title":"p21 in cancer: intricate networks and multiple activities","volume":"9","author":"Abbas","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2025.118097_bib9","first-page":"639","article-title":"The role of the cyclin-dependent kinase inhibitor p21 in apoptosis","volume":"1","author":"Gartel","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biopha.2025.118097_bib10","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026104","article-title":"The Cell-Cycle Arrest and Apoptotic Functions of p53 in Tumor Initiation and Progression","volume":"6","author":"Chen","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.biopha.2025.118097_bib11","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","article-title":"The somatic genomic landscape of glioblastoma","volume":"155","author":"Brennan","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2025.118097_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10090297","article-title":"The p53 pathway in glioblastoma","volume":"10","author":"Zhang","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.biopha.2025.118097_bib13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41586-022-05551-x","article-title":"BRD8 maintains glioblastoma by epigenetic reprogramming of the p53 network","volume":"613","author":"Sun","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.118097_bib14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1517\/13543776.2013.746313","article-title":"Naphthalimide derivatives with therapeutic characteristics: a patent review","volume":"23","author":"Kamal","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.biopha.2025.118097_bib15","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/tcr.201600134","article-title":"1,8-Naphthalimide: A Potent DNA Intercalator and Target for Cancer Therapy","volume":"17","author":"Tandon","year":"2017","journal-title":"Chem. Rec."},{"key":"10.1016\/j.biopha.2025.118097_bib16","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1021\/jm100025u","article-title":"A new class of naphthalimide-based antitumor agents that inhibit topoisomerase II and induce lysosomal membrane permeabilization and apoptosis","volume":"53","author":"Chen","year":"2010","journal-title":"J. Med Chem."},{"key":"10.1016\/j.biopha.2025.118097_bib17","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3389\/fchem.2020.00166","article-title":"A polyamine-based dinitro-naphthalimide conjugate as substrates for polyamine transporters preferentially accumulates in cancer cells and minimizes side effects in vitro and in vivo","volume":"8","author":"Ma","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.biopha.2025.118097_bib18","doi-asserted-by":"crossref","first-page":"5349","DOI":"10.1039\/C8OB02973C","article-title":"Synthesis and in vitro evaluation of naphthalimide-benzimidazole conjugates as potential antitumor agents","volume":"17","author":"Singh","year":"2019","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.biopha.2025.118097_bib19","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1021\/jm070315q","article-title":"2,2,2-Trichloro-N-({2-[2-(dimethylamino)ethyl]-1,3-dioxo-2,3-dihydro-1H-benzo[de] isoquinolin- 5-yl}carbamoyl)acetamide (UNBS3157), a novel nonhematotoxic naphthalimide derivative with potent antitumor activity","volume":"50","author":"Van Quaquebeke","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2025.118097_bib20","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s11033-019-05239-y","article-title":"Synthesis of naphthalimide derivatives with potential anticancer activity, their comparative ds- and G-quadruplex-DNA binding studies and related biological activities","volume":"47","author":"Yildiz","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.biopha.2025.118097_bib21","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/jccs.202000019","article-title":"Discovery of a more potent anticancer agent than C4-benzazole 1,8-naphthalimide derivatives against murine melanoma","volume":"67","author":"Tung","year":"2020","journal-title":"J. Chin. Chem. Soc."},{"key":"10.1016\/j.biopha.2025.118097_bib22","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1016\/j.ejmech.2011.04.058","article-title":"Development of novel naphthalimide derivatives and their evaluation as potential melanoma therapeutics","volume":"46","author":"Sk","year":"2011","journal-title":"Eur. J. Med Chem."},{"key":"10.1016\/j.biopha.2025.118097_bib23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.thromres.2023.03.017","article-title":"Paclitaxel exerts antiplatelet and antithrombotic activities: additional benefit from use of paclitaxel-coated balloons and -eluting stents in coronary revascularization and prevention of in-stent restenosis","volume":"225","author":"Lin","year":"2023","journal-title":"Thromb. Res."},{"key":"10.1016\/j.biopha.2025.118097_bib24","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrc991","article-title":"Inhibiting the p53-MDM2 interaction: an important target for cancer therapy","volume":"3","author":"Chene","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2025.118097_bib25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0092-8674(03)00755-4","article-title":"Proteasome-mediated degradation of p21 via N-terminal ubiquitinylation","volume":"115","author":"Bloom","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2025.118097_bib26","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41392-023-01692-1","article-title":"Going only half the way: cell cycle exit after the G1 restriction point","volume":"8","author":"Muller","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.biopha.2025.118097_bib27","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1158\/2159-8290.CD-23-0954","article-title":"INX-315, a Selective CDK2 inhibitor, induces cell cycle arrest and senescence in solid tumors","volume":"14","author":"Dietrich","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.biopha.2025.118097_bib28","doi-asserted-by":"crossref","first-page":"39193","DOI":"10.1074\/jbc.M112.391854","article-title":"Cyclin-dependent kinase-1 (Cdk1)\/cyclin B1 dictates cell fate after mitotic arrest via phosphoregulation of antiapoptotic Bcl-2 proteins","volume":"287","author":"Sakurikar","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118097_bib29","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1158\/1535-7163.MCT-06-0727","article-title":"Increased expression of cyclin B1 sensitizes prostate cancer cells to apoptosis induced by chemotherapy","volume":"6","author":"Gomez","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biopha.2025.118097_bib30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/mc.21956","article-title":"Role of cyclin B1\/Cdc2 in mediating Bcl-XL phosphorylation and apoptotic cell death following nocodazole-induced mitotic arrest","volume":"53","author":"Choi","year":"2014","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.biopha.2025.118097_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/cells10081877","article-title":"The Combined Treatment with Chemotherapeutic Agents and the Dualsteric Muscarinic Agonist Iper-8-Naphthalimide Affects Drug Resistance in Glioblastoma Stem Cells","volume":"10","author":"Guerriero","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2025.118097_bib32","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF01058464","article-title":"Phase II study of amonafide in patients with recurrent glioma","volume":"23","author":"Levitt","year":"1995","journal-title":"J. Neurooncol"},{"key":"10.1016\/j.biopha.2025.118097_bib33","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.molmed.2017.02.001","article-title":"p21: A two-faced genome guardian","volume":"23","author":"Georgakilas","year":"2017","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.biopha.2025.118097_bib34","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/bbrc.2000.2247","article-title":"p21(WAF1\/CIP1) inhibits initiator caspase cleavage by TRAIL death receptor DR4","volume":"269","author":"Xu","year":"2000","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.biopha.2025.118097_bib35","doi-asserted-by":"crossref","first-page":"6654","DOI":"10.1128\/MCB.16.12.6654","article-title":"Protective role of p21(Waf1\/Cip1) against prostaglandin A2-mediated apoptosis of human colorectal carcinoma cells","volume":"16","author":"Gorospe","year":"1996","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2025.118097_bib36","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1038\/sj.onc.1210283","article-title":"Dose-response transition from cell cycle arrest to apoptosis with selective degradation of Mdm2 and p21WAF1\/CIP1 in response to the novel anticancer agent, aminoflavone (NSC 686,288)","volume":"26","author":"Meng","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2025.118097_bib37","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/gb4184","article-title":"Cyclin-dependent kinases","volume":"15","author":"Malumbres","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.biopha.2025.118097_bib38","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.bbamcr.2012.05.003","article-title":"Critical role of cyclin B1\/Cdc2 up-regulation in the induction of mitotic prometaphase arrest in human breast cancer cells treated with 2-methoxyestradiol","volume":"1823","author":"Choi","year":"2012","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.biopha.2025.118097_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2019.02.014","article-title":"Upregulated cyclin B1\/CDK1 mediates apoptosis following 2-methoxyestradiol-induced mitotic catastrophe: Role of Bcl-X(L) phosphorylation","volume":"150","author":"Choi","year":"2019","journal-title":"Steroids"},{"key":"10.1016\/j.biopha.2025.118097_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024312","article-title":"Role of cyclin B1\/Cdc2 up-regulation in the development of mitotic prometaphase arrest in human breast cancer cells treated with nocodazole","volume":"6","author":"Choi","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.118097_bib41","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1038\/s41467-023-40087-2","article-title":"Structures of p53\/BCL-2 complex suggest a mechanism for p53 to antagonize BCL-2 activity","volume":"14","author":"Wei","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.118097_bib42","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S1097-2765(03)00050-9","article-title":"p53 has a direct apoptogenic role at the mitochondria","volume":"11","author":"Mihara","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.biopha.2025.118097_bib43","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/ncb1123","article-title":"Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex","volume":"6","author":"Leu","year":"2004","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.biopha.2025.118097_bib44","doi-asserted-by":"crossref","first-page":"21294","DOI":"10.1074\/jbc.M710539200","article-title":"Oligomerization of BAK by p53 utilizes conserved residues of the p53 DNA binding domain","volume":"283","author":"Pietsch","year":"2008","journal-title":"J. Biol. Chem."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225002914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225002914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T19:55:26Z","timestamp":1759002926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225002914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":44,"alternative-id":["S0753332225002914"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118097","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Naphthalimide derivative attenuates tumor growth of wild-type p53\u2013expressing U87 glioma cells in vitro and in vivo through a biphasic dose-dependent mechanism: A switch from cell cycle to apoptosis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118097","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118097"}}